Showing results (71-80 of 85) with videos related to

Sort By:
Pageof 9
Oncology|January 1, 1986
Different sensitivity of two Walker 256 carcinoma lines to cyclophosphamide: correlation with drug distribution, biotransformation and macromolecule bindingM G Donelli, A Guaitani, L Torti, et al.
International Surgery|January 1, 1992
Single lung transplantation for emphysema. Lessons learned on the field. The Lung Transplant Group of the Ospedale Maggiore of MilanP Zannini, A Baisi, G Melloni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 1991
Natural killer (NK) and lymphokine activated killer (LAK) cell activity in patients (PTS) treated with flavone acetic acid (FAA)E Galligioni, M Quaia, A Spada, et al.
Intensive Care Medicine|January 1, 1984
The main determinants of nitrogen balance during total parenteral nutrition in critically ill injured patientsG Iapichino, D Radrizzani, M Solca, et al.
Leukemia Research|November 1, 1993
Cytotoxic activity and mechanism of action of 5-Aza-2'-deoxycytidine in human CML cellsM Limonta, T Colombo, G Damia, et al.
Clinical Nutrition (Edinburgh, Scotland)|August 1, 1985
Parenteral nutrition of injured patients: Effect of manipulation of aminoacid infusion (increasing branched chain while decreasing aromatic and sulphurated aminoacids)G Iapichino, D Radrizzani, G Bonetti, et al.
The Journal of Experimental Medicine|September 1, 1994
Recombinant transforming growth factor beta 1 and beta 2 protect mice from acutely lethal doses of 5-fluorouracil and doxorubicinK Grzegorzewski, F W Ruscetti, N Usui, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 15, 1991
Effects of recombinant transforming growth factor-beta 1 on hematologic recovery after treatment of mice with 5-fluorouracilR Jansen, G Damia, N Usui, et al.
Oncology Research|January 26, 2005
The unique biological features of the marine product Yondelis (ET-743, trabectedin) are shared by its analog ET-637, which lacks the C ringE Erba, E Cavallaro, G Damia, et al.
Cancer Research|August 1, 1992
Prevention of acute chemotherapy-induced death in mice by recombinant human interleukin 1: protection from hematological and nonhematological toxicitiesG Damia, K L Komschlies, H Futami, et al.
Pageof 9